Suppr超能文献

儿童肝肾移植受者药物依从性的促进因素和障碍:一项混合方法研究。

Facilitators and barriers of medication adherence in pediatric liver and kidney transplant recipients: a mixed-methods study.

作者信息

Claes Anouck, Decorte Anneloes, Levtchenko Elena, Knops Noel, Dobbels Fabienne

机构信息

University of Leuven, Leuven, Belgium.

University Hospitals of Leuven, Leuven, Belgium.

出版信息

Prog Transplant. 2014 Dec;24(4):311-21. doi: 10.7182/pit2014873.

Abstract

OBJECTIVE

Many young transplant patients (≤11 years old) struggle to take their immunosuppressive and co-medications correctly, yet it remains unclear which factors positively or negatively affect medication adherence. Research studies on determinants in this age group are scarce, have methodological flaws, and focus exclusively on immunosuppressants or on barriers rather than on facilitators.

METHODS

This study used a consecutive mixed-methods (qualitative + quantitative) design. Semistructured interviews with parents of 10 pediatric liver or kidney transplant recipients 2 to 11 years old on adherence facilitators and barriers were conducted, complemented by quantification of adherence to the immunosuppressants and co-medications, and completion of the "immunosuppressive medication adherence barriers" self-report instrument.

RESULTS

A median of 19 (range, 10-29) barriers was reported: the most commonly encountered were forgetfulness (70%), vomiting (70%), bad taste (60%), and interruptions in routine (60%). Parents reported a median of 15 facilitators (range, 6-26), including using practical aids (100%), having medication with you at all times (100%), having to take fewer medications (80%), and experiencing fewer regimen changes over time (80%). No clear distinction between immunosuppressants or co-medications was made.

CONCLUSIONS

This study provides several new insights based on peer experience to support future patients and their parents in medication adherence.

摘要

目的

许多年轻的移植患者(≤11岁)在正确服用免疫抑制剂和辅助药物方面存在困难,但尚不清楚哪些因素对药物依从性有正面或负面影响。关于该年龄组决定因素的研究很少,存在方法学缺陷,并且仅专注于免疫抑制剂或障碍而非促进因素。

方法

本研究采用连续混合方法(定性+定量)设计。对10名2至11岁的小儿肝或肾移植受者的父母进行了关于依从性促进因素和障碍的半结构化访谈,并辅以免疫抑制剂和辅助药物依从性的量化,以及完成“免疫抑制药物依从性障碍”自我报告工具。

结果

报告的障碍中位数为19(范围10-29):最常见的是健忘(70%)、呕吐(70%)、味道差(60%)和日常安排中断(60%)。父母报告的促进因素中位数为15(范围6-26),包括使用实用辅助工具(100%)、随时携带药物(100%)、需要服用的药物较少(80%)以及随着时间推移方案变化较少(80%)。免疫抑制剂和辅助药物之间没有明显区别。

结论

本研究基于同行经验提供了一些新见解,以支持未来患者及其父母的药物依从性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验